Delivery Order SPE2DB22D2211-SPE2DB24FNTE9

Award Date 6/14/24
Potential Completion Date 6/17/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FNTE9
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a delivery order contract worth $2,778.80 for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. As a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally, Amerisourcebergen Drug Corp leverages its parent company's extensive supply chain to efficiently fulfill government contracts, including those with the Department of Justice Federal Bureau of Investigation.

Generated 9/13/24, 10:04 AM